Market closed
Quest Diagnostics/$DGX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Quest Diagnostics
Quest Diagnostics Inc is a leading independent provider of diagnostic testing, information, and services in the us. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.
Ticker
$DGX
Sector
Trading on
NYSE
Industry
Health Care Providers & Services
Headquarters
Employees
55,000
Website
DGX Metrics
BasicAdvanced
$20B
22.24
$7.91
0.78
$3.05
1.82%
Price and volume
Market cap
$20B
Beta
0.78
52-week high
$178.87
52-week low
$134.05
Average daily volume
1.5M
Dividend rate
$3.05
Financial strength
Current ratio
1.44
Quick ratio
1.105
Long term debt to equity
90.814
Total debt to equity
93.284
Dividend payout ratio (TTM)
37.46%
Interest coverage (TTM)
5.83%
Management effectiveness
Return on assets (TTM)
6.13%
Return on equity (TTM)
13.95%
Valuation
Price to earnings (TTM)
22.24
Price to revenue (TTM)
1.922
Price to book
2.84
Price to tangible book (TTM)
-5.4
Price to free cash flow (TTM)
18.486
Dividend yield (TTM)
1.73%
Forward dividend yield
1.82%
Growth
Revenue change (TTM)
9.38%
Earnings per share change (TTM)
6.41%
3-year revenue growth (CAGR)
-1.65%
3-year earnings per share growth (CAGR)
-19.35%
3-year dividend per share growth (CAGR)
6.57%
What the Analysts think about DGX
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Quest Diagnostics stock.
DGX Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
DGX Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
DGX News
AllArticlesVideos
These Analysts Boost Their Forecasts On Quest Diagnostics After Better-Than-Expected Q1 Earnings
Benzinga·2 days ago
Quest Diagnostics Revenue Rebound, Strategic Moves Fuel Outlook Confidence
Benzinga·3 days ago
Quest Diagnostics Incorporated (DGX) Q1 2025 Earnings Call Transcript
Seeking Alpha·3 days ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Quest Diagnostics stock?
Quest Diagnostics (DGX) has a market cap of $20B as of April 26, 2025.
What is the P/E ratio for Quest Diagnostics stock?
The price to earnings (P/E) ratio for Quest Diagnostics (DGX) stock is 22.24 as of April 26, 2025.
Does Quest Diagnostics stock pay dividends?
Yes, the Quest Diagnostics (DGX) stock pays dividends to shareholders. As of April 26, 2025, the dividend rate is $3.05 and the yield is 1.82%. Quest Diagnostics has a payout ratio of 37.46% on a trailing twelve-month basis.
When is the next Quest Diagnostics dividend payment date?
The next Quest Diagnostics (DGX) dividend payment date is unconfirmed.
What is the beta indicator for Quest Diagnostics?
Quest Diagnostics (DGX) has a beta rating of 0.78. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.